189 related articles for article (PubMed ID: 24075964)
1. Reflux induces DNA strand breaks and expression changes of MMP1+9+14 in a human miniorgan culture model.
Sandner A; Illert J; Koitzsch S; Unverzagt S; Schön I
Exp Cell Res; 2013 Nov; 319(19):2905-15. PubMed ID: 24075964
[TBL] [Abstract][Full Text] [Related]
2. ATF3-Dependent Regulation of EGR1 in vitro and in vivo.
Schoen I; Koitzsch S
ORL J Otorhinolaryngol Relat Spec; 2017; 79(5):239-250. PubMed ID: 28803237
[TBL] [Abstract][Full Text] [Related]
3. Expression of a dominant-negative mutant inhibitor-kappaBalpha of nuclear factor-kappaB in human head and neck squamous cell carcinoma inhibits survival, proinflammatory cytokine expression, and tumor growth in vivo.
Duffey DC; Chen Z; Dong G; Ondrey FG; Wolf JS; Brown K; Siebenlist U; Van Waes C
Cancer Res; 1999 Jul; 59(14):3468-74. PubMed ID: 10416612
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinase-2 and -14 in p16-positive and -negative HNSCC after exposure To 5-FU and docetaxel In Vitro.
Aderhold C; Umbreit C; Faber A; Birk R; Sommer JU; Hörmann K; Schultz JD
Anticancer Res; 2014 Sep; 34(9):4929-37. PubMed ID: 25202075
[TBL] [Abstract][Full Text] [Related]
5. Analysis of preoperative serum levels of MMP1, -2, and -9 in patients with site-specific head and neck squamous cell cancer.
Kalfert D; Ludvikova M; Topolcan O; Windrichova J; Malirova E; Pesta M; Celakovsky P
Anticancer Res; 2014 Dec; 34(12):7431-41. PubMed ID: 25503184
[TBL] [Abstract][Full Text] [Related]
6. [Association between the expression of MMP1 gene and prognosis in head and neck squamous cell carcinoma].
Liu LQ; Chen ZW; Yi SJ
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Feb; 32(4):287-291. PubMed ID: 29798507
[No Abstract] [Full Text] [Related]
7. Keratinocytes and head and neck squamous cell carcinoma cells regulate urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in fibroblasts.
Hakelius M; Koskela A; Ivarsson M; Grenman R; Rubin K; Gerdin B; Nowinski D
Anticancer Res; 2013 Aug; 33(8):3113-8. PubMed ID: 23898067
[TBL] [Abstract][Full Text] [Related]
8. MMP1 Overexpression Promotes Cancer Progression and Associates with Poor Outcome in Head and Neck Carcinoma.
Zhang W; Huang X; Huang R; Zhu H; Ye P; Lin X; Zhang S; Wu M; Jiang F
Comput Math Methods Med; 2022; 2022():3058342. PubMed ID: 36105241
[TBL] [Abstract][Full Text] [Related]
9. Silencing heat shock protein 27 decreases metastatic behavior of human head and neck squamous cell cancer cells in vitro.
Zhu Z; Xu X; Yu Y; Graham M; Prince ME; Carey TE; Sun D
Mol Pharm; 2010 Aug; 7(4):1283-90. PubMed ID: 20540527
[TBL] [Abstract][Full Text] [Related]
10. Expression profiles and clinical correlations of degradome components in the tumor microenvironment of head and neck squamous cell carcinoma.
Stokes A; Joutsa J; Ala-Aho R; Pitchers M; Pennington CJ; Martin C; Premachandra DJ; Okada Y; Peltonen J; Grénman R; James HA; Edwards DR; Kähäri VM
Clin Cancer Res; 2010 Apr; 16(7):2022-35. PubMed ID: 20305301
[TBL] [Abstract][Full Text] [Related]
11. Early Growth Response 1-Dependent Downregulation of Matrix Metalloproteinase 9 and Mouse Double Minute 2 Attenuates Head and Neck Squamous Cell Carcinoma Metastasis.
Kim J; Kang SM; Oh SY; Kang SH; Lee I; Hwang JC; Lee HJ; Choi SY; Hong SH
Cell Physiol Biochem; 2018; 50(5):1869-1881. PubMed ID: 30396177
[TBL] [Abstract][Full Text] [Related]
12. Expression of matrix metalloproteinase 1, matrix metalloproteinase 2, and matrix metalloproteinase 9 in carcinoma of the head and neck.
Franchi A; Santucci M; Masini E; Sardi I; Paglierani M; Gallo O
Cancer; 2002 Nov; 95(9):1902-10. PubMed ID: 12404284
[TBL] [Abstract][Full Text] [Related]
13. Coexpression of proangiogenic factors IL-8 and VEGF by human head and neck squamous cell carcinoma involves coactivation by MEK-MAPK and IKK-NF-kappaB signal pathways.
Bancroft CC; Chen Z; Dong G; Sunwoo JB; Yeh N; Park C; Van Waes C
Clin Cancer Res; 2001 Feb; 7(2):435-42. PubMed ID: 11234901
[TBL] [Abstract][Full Text] [Related]
14. A functional polymorphism in the matrix metalloproteinase-1 gene promoter is associated with susceptibility and aggressiveness of head and neck cancer.
O-charoenrat P; Leksrisakul P; Sangruchi S
Int J Cancer; 2006 May; 118(10):2548-53. PubMed ID: 16353148
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinase 1: a better biomarker for squamous cell carcinoma by multiple microarray analyses.
Zheng LQ; Wang R; Chi SM; Li CX
G Ital Dermatol Venereol; 2019 Jun; 154(3):327-337. PubMed ID: 29249121
[TBL] [Abstract][Full Text] [Related]
16. In vivo Wnt pathway inhibition of human squamous cell carcinoma growth and metastasis in the chick chorioallantoic model.
Rudy SF; Brenner JC; Harris JL; Liu J; Che J; Scott MV; Owen JH; Komarck CM; Graham MP; Bellile EL; Bradford CR; Prince ME; Carey TE
J Otolaryngol Head Neck Surg; 2016 Apr; 45():26. PubMed ID: 27117272
[TBL] [Abstract][Full Text] [Related]
17. p120-Catenin Downregulation and
Kidacki M; Lehman HL; Green MV; Warrick JI; Stairs DB
Mol Cancer Res; 2017 Oct; 15(10):1398-1409. PubMed ID: 28637905
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-375 Suppresses Extracellular Matrix Degradation and Invadopodial Activity in Head and Neck Squamous Cell Carcinoma.
Jimenez L; Sharma VP; Condeelis J; Harris T; Ow TJ; Prystowsky MB; Childs G; Segall JE
Arch Pathol Lab Med; 2015 Nov; 139(11):1349-61. PubMed ID: 26172508
[TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinases MMP1, MMP2, MMP9 and their tissue inhibitors TIMP1, TIMP2, TIMP3 in head and neck cancer: an immunohistochemical study.
Pietruszewska W; Bojanowska-Poźniak K; Kobos J
Otolaryngol Pol; 2016 Jun; 70(3):32-43. PubMed ID: 27386931
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the matrix metalloproteinase 9 (MMP9) inhibitor Andecaliximab as an Anti-invasive therapeutic in Head and neck squamous cell carcinoma.
Allen JL; Hames RA; Mastroianni NM; Greenstein AE; Weed SA
Oral Oncol; 2022 Sep; 132():106008. PubMed ID: 35803110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
